The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
DIREXION SHS ETF TR | DLY S&P500 BR 3X | 25460E265 | 886 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
MUSTANG BIO INC | COM | 62818Q104 | 9 | 18,600 | SH | SOLE | 18,600 | 0 | 0 | ||
PROSHARES TR | PSHS ULTSH 20YRS | 74347B201 | 929 | 29,200 | SH | SOLE | 29,200 | 0 | 0 | ||
PROSHARES TR | ULTRAPRO SHT QQQ | 74347G432 | 858 | 14,000 | SH | SOLE | 14,000 | 0 | 0 | ||
SOBR SAFE INC | COM NEW | 833592207 | 42 | 15,500 | SH | SOLE | 15,500 | 0 | 0 |